Acetyl Hexapeptide-3
Acetyl Hexapeptide-3
Also known as: Argireline, Acetyl Hexapeptide-8, SNAP-6
Overview
Key Facts
Primary Goal: Research and therapeutic applications of Acetyl Hexapeptide-3
Competes with SNAP-25 for incorporation into the SNARE complex. Reduces vesicle docking and acetylcholine release at neuromuscular junctions.
Dosing Information
~3-5 hours (topical activity window)
5–10 mg
Twice daily (topical application)
Continuous daily use; initial effects within 2-4 weeks, full results at 8-12 weeks
Benefits
- Reduces expression wrinkles (forehead, crow's feet, glabella) by up to 30%
- Non-invasive alternative to botulinum toxin injections
- Reduces depth of fine lines from repetitive facial movements
- Compatible with most skincare ingredients
- No muscle paralysis — reduces contraction intensity rather than blocking it
Side Effects
Mechanism of Action
Competes with SNAP-25 for incorporation into the SNARE complex
Reduces vesicle docking and acetylcholine release at neuromuscular junctions
Attenuates muscle contraction intensity without full paralysis
Dose-dependent inhibition of catecholamine release demonstrated in vitro
Contraindications
Do not use this peptide if any of the following apply:
- Concurrent botulinum toxin injections in the same area (compounding effect unclear)
- Known allergy to peptide ingredients
- Application on broken or severely inflamed skin
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Developed by Lipotec (now part of Lubrizol), Argireline was introduced in 2002 and quickly became a bestselling cosmetic peptide. In vitro studies showed 41% inhibition of SNARE complex formation at 0.05 mM. A 30-day clinical study demonstrated a 30% reduction in wrinkle depth around the eyes. While less potent than injectable botulinum toxin, its non-invasive nature and good safety profile have made it one of the most commercially successful cosmetic peptides globally.
Frequently Asked Questions
Common questions about Acetyl Hexapeptide-3
UK-Specific Information
Exclusive data points and guidance for UK residents using Acetyl Hexapeptide-3
UK Lab Testing
UK Lab Testing
Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
AOD-9604
Research and therapeutic applications of AOD-9604
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.
Share on TikTok
Generate a trackable link to share this peptide information on TikTok